AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 171 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $734,000 | -25.3% | 97,662 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $982,000 | -9.7% | 97,662 | -7.5% | 0.00% | 0.0% |
Q1 2022 | $1,087,000 | -54.8% | 105,591 | +0.5% | 0.00% | -50.0% |
Q4 2021 | $2,404,000 | -4.6% | 105,111 | -7.7% | 0.00% | 0.0% |
Q3 2021 | $2,521,000 | +70.7% | 113,936 | 0.0% | 0.00% | +100.0% |
Q2 2021 | $1,477,000 | -5.0% | 113,936 | -4.8% | 0.00% | -50.0% |
Q1 2021 | $1,554,000 | -10.7% | 119,670 | -5.0% | 0.00% | 0.0% |
Q4 2020 | $1,741,000 | -12.5% | 125,920 | -6.7% | 0.00% | -33.3% |
Q3 2020 | $1,989,000 | -36.5% | 134,997 | -30.0% | 0.00% | -25.0% |
Q2 2020 | $3,134,000 | -44.0% | 192,853 | -50.0% | 0.00% | -20.0% |
Q1 2020 | $5,596,000 | +1.4% | 385,706 | +41.6% | 0.01% | -28.6% |
Q4 2019 | $5,517,000 | +279.4% | 272,298 | 0.0% | 0.01% | +250.0% |
Q3 2019 | $1,454,000 | +3131.1% | 272,298 | +3844.1% | 0.00% | – |
Q2 2019 | $45,000 | 0.0% | 6,904 | 0.0% | 0.00% | – |
Q1 2019 | $45,000 | – | 6,904 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |